{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["EGCG", "Maesa perlarius", "anti-Ebola virus activity", "condensed tannin", "flavan-3-ol", "procyanidin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35269770", "DateCompleted": {"Year": "2022", "Month": "04", "Day": "08"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "27"}], "Language": ["eng"], "ELocationID": ["2620", "10.3390/ijms23052620"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "5", "PubDate": {"Year": "2022", "Month": "Feb", "Day": "27"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Ebola Entry Inhibitors Discovered from <i>Maesa perlarius</i>.", "Abstract": {"AbstractText": ["Ebola virus disease (EVD), a disease caused by infection with Ebola virus (EBOV), is characterized by hemorrhagic fever and a high case fatality rate. With limited options for the treatment of EVD, anti-Ebola viral therapeutics need to be urgently developed. In this study, over 500 extracts of medicinal plants collected in the Lingnan region were tested against infection with Ebola-virus-pseudotyped particles (EBOVpp), leading to the discovery of <i>Maesa perlarius</i> as an anti-EBOV plant lead. The methanol extract (MPBE) of the stems of this plant showed an inhibitory effect against EBOVpp, with an IC<sub>50</sub> value of 0.52 \u00b5g/mL, which was confirmed by testing the extract against infectious EBOV in a biosafety level 4 laboratory. The bioassay-guided fractionation of MPBE resulted in three proanthocyanidins (procyanidin B2 (<b>1</b>), procyanidin C1 (<b>2</b>), and epicatechin-(4<i>\u03b2</i>\u21928)-epicatechin-(4<i>\u03b2</i>\u21928)-epicatechin-(4\u03b2\u21928)-epicatechin (<b>3</b>)), along with two flavan-3-ols ((+)-catechin (<b>4</b>) and (-)-epicatechin (<b>5</b>)). The IC<sub>50</sub> values of the compounds against pseudovirion-bearing EBOV-GP ranged from 0.83 to 36.0 \u00b5M, with <b>1</b> as the most potent inhibitor. The anti-EBOV activities of five synthetic derivatives together with six commercially available analogues, including EGCG ((-)-epigallocatechin-3-<i>O</i>-gallate (<b>8</b>)), were further investigated. Molecular docking analysis and binding affinity measurement suggested the EBOV glycoprotein could be a potential molecular target for <b>1</b> and its related compounds."]}, "AuthorList": [{"Identifier": ["0000-0002-8273-3114"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Teaching and Research Division, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong, China."}], "LastName": "Tsang", "ForeName": "Nga Yi", "Initials": "NY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Teaching and Research Division, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong, China."}], "LastName": "Li", "ForeName": "Wan-Fei", "Initials": "WF"}, {"Identifier": ["0000-0001-5229-7465"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, College of Medicine, University of Illinois Chicago, 909 South Wolcott Ave, Chicago, IL 60612, USA."}], "LastName": "Varhegyi", "ForeName": "Elizabeth", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, College of Medicine, University of Illinois Chicago, 909 South Wolcott Ave, Chicago, IL 60612, USA."}], "LastName": "Rong", "ForeName": "Lijun", "Initials": "L"}, {"Identifier": ["0000-0002-7175-5166"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Teaching and Research Division, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong, China."}], "LastName": "Zhang", "ForeName": "Hong-Jie", "Initials": "HJ"}], "GrantList": [{"GrantID": "HKBU 12103917", "Agency": "The Research Grants Council of the Hong Kong Special Administrative Region, China", "Country": ""}, {"GrantID": "HKBU 12103618", "Agency": "The Research Grants Council of the Hong Kong Special Administrative Region, China", "Country": ""}, {"GrantID": "AI77767", "Agency": "National Institutes of Health (NIH)", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "HIV Fusion Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "8R1V1STN48", "NameOfSubstance": "Catechin"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Catechin"}, {"QualifierName": [], "DescriptorName": "Ebolavirus"}, {"QualifierName": ["pharmacology"], "DescriptorName": "HIV Fusion Inhibitors"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Hemorrhagic Fever, Ebola"}, {"QualifierName": [], "DescriptorName": "Maesa"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Centers for Disease Control and Prevention (CDC)  Signs and Symptoms (Ebola Virus)  [(accessed on 1 February 2022)]; Available online:  https://www.cdc.gov/vhf/ebola/symptoms/index.html."}, {"Citation": "World Health Organization (WHO)   World Health Organization;  [(accessed on 1 February 2022)]. Ebola Virus Disease. Available online:  https://www.afro.who.int/health-topics/ebola-virus-disease."}, {"Citation": "Centers for Disease Control and Prevention (CDC)  History of Ebola Virus Disease (EVD) Outbreaks.  [(accessed on 1 February 2022)]; Available online:  https://www.cdc.gov/vhf/ebola/history/chronology.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvhf%2Febola%2Foutbreaks%2Fhistory%2Fchronology.html."}, {"Citation": "Schafer A., Xiong R., Cooper L., Nowar R., Lee H., Li Y., Ramirez B.E., Peet N.P., Caffrey M., Thatcher G.R.J., et al. Evidence for distinct mechanisms of small molecule inhibitors of filoviral entry. PLoS Pathog. 2021;17:e1009312. doi: 10.1371/journal.ppat.1009312.", "ArticleIdList": ["10.1371/journal.ppat.1009312", "PMC7888603", "33539432"]}, {"Citation": "Zhang H.J., Rumschlag-Booms E., Guan Y.F., Wang D.Y., Liu K.L., Li W.F., Nguyen V.H., Cuong N.M., Soejarto D.D., Fong H.H.S., et al. Potent inhibitor of drug-resistant HIV-1 strains identified from the medicinal plant Justicia gendarussa. J. Nat. Prod. 2017;80:1798\u20131807. doi: 10.1021/acs.jnatprod.7b00004.", "ArticleIdList": ["10.1021/acs.jnatprod.7b00004", "28613071"]}, {"Citation": "Rumschlag-Booms E., Zhang H., Soejarto D.D., Fong H.H.S., Rong L. Development of an antiviral screening protocol: One-Stone-Two-Birds. J. Antivir. Antiretrovir. 2011;3:8\u201310. doi: 10.4172/jaa.1000027.", "ArticleIdList": ["10.4172/jaa.1000027", "PMC3227027", "22140608"]}, {"Citation": "Li W.F., Wang J., Zhang J.J., Song X., Ku C.F., Zou J., Li J.X., Rong L.J., Pan L.T., Zhang H.J. Henrin A: A new anti-HIV ent-kaurane diterpene from Pteris henryi. Int. J. Mol. Sci. 2015;16:27978\u201327987. doi: 10.3390/ijms161126071.", "ArticleIdList": ["10.3390/ijms161126071", "PMC4661929", "26610490"]}, {"Citation": "Zhang H.J., Rumschlag-Booms E., Guan Y.F., Liu K.L., Wang D.Y., Li W.F., Nguyen V.H., Cuong N.M., Soejarto D.D., Fong H.H.S., et al. Anti-HIV diphyllin glycosides from Justicia gendarussa. Phytochemistry. 2017;136:94\u2013100. doi: 10.1016/j.phytochem.2017.01.005.", "ArticleIdList": ["10.1016/j.phytochem.2017.01.005", "28110956"]}, {"Citation": "Xu X.Y., Wang D.Y., Ku K.F., Zhao Y., Cheng H., Liu K.L., Rong L.J., Zhang H.J. Anti-HIV lignans from Justicia procumbens. Chin. J. Nat. Med. 2019;17:945\u2013952. doi: 10.1016/S1875-5364(19)30117-7.", "ArticleIdList": ["10.1016/S1875-5364(19)30117-7", "31882050"]}, {"Citation": "Kos J., Ku C.F., Kapustikova I., Oravec M., Zhang H.J., Jampilek J. 8-Hydroxyquinoline-2-carboxanilides as antiviral agents against avian influenza virus. ChemistrySelect. 2019;4:4582\u20134587. doi: 10.1002/slct.201900873.", "ArticleIdList": ["10.1002/slct.201900873"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 2020;83:770\u2013803. doi: 10.1021/acs.jnatprod.9b01285.", "ArticleIdList": ["10.1021/acs.jnatprod.9b01285", "32162523"]}, {"Citation": "Sang W., Ma K., Axmacher J.C. Securing a future for China\u2019s wild plant resources. Bioscience. 2011;61:720\u2013725. doi: 10.1525/bio.2011.61.9.11.", "ArticleIdList": ["10.1525/bio.2011.61.9.11"]}, {"Citation": "Hu S.W. Ancient History of Lingnan. 1st ed. Guangdong People\u2019s Publishing House; Guangzhou, China: 2014."}, {"Citation": "Maesa perlarius (Loureiro) Merrill.  [(accessed on 1 February 2022)].  Available online:  http://www.efloras.org/florataxon.aspx?flora_id=2&taxon_id=200016864."}, {"Citation": "Wiart C. Maesa perlarius (Lour.) Merr. In: Wiart C., editor. Medicinal Plants of Asia and the Pacific. CRC Press; Boca Raton, FL, USA: 2006. pp. 67\u201368."}, {"Citation": "Sindambiwe J.B., Bald\u00e9 A.M., De Bruyne T., Pieters L., Van denHeuvel H., Claeys M., Van den Berghe D.A., Vlietinck A.J. Triterpenoid saponins from Maesa lanceolata. Phytochemistry. 1996;41:269\u2013277. doi: 10.1016/0031-9422(95)00552-8.", "ArticleIdList": ["10.1016/0031-9422(95)00552-8", "8588869"]}, {"Citation": "Untiwachwuttikul P., Pancharoen O., Mahubusarakam W., Wiriyachitra P., Taylor W.C., Bubb W.A., Towers G.H.N. A triterpenoid saponin from Maesa ramentacea. Phytochemistry. 1997;44:491\u2013495. doi: 10.1016/S0031-9422(96)00556-0.", "ArticleIdList": ["10.1016/S0031-9422(96)00556-0", "9014372"]}, {"Citation": "Apers S., De Bruyne T.E., Claeys M., Vlietinck A.J., Pieters L.A.C. New acylated triterpenoid saponins from Maesa lanceolata. Phytochemistry. 1999;52:1121\u20131131. doi: 10.1016/S0031-9422(99)00352-0.", "ArticleIdList": ["10.1016/S0031-9422(99)00352-0", "10643673"]}, {"Citation": "Manguro L.O.A., Midiwo J.O., Tietze L.F., Hao P. Triterpene saponins of Maesa lanceolata leaves. Arkivoc. 2011;2011:172\u2013198. doi: 10.3998/ark.5550190.0012.214.", "ArticleIdList": ["10.3998/ark.5550190.0012.214"]}, {"Citation": "Germonprez N., Van Puyvelde L., Maes L., Van Tri M., De Kimpe N. New pentacyclic triterpene saponins with strong anti-leishmanial activity from the leaves of Maesa balansae. Tetrahedron. 2004;60:219\u2013228. doi: 10.1016/j.tet.2003.09.042.", "ArticleIdList": ["10.1016/j.tet.2003.09.042"]}, {"Citation": "Wall M.E., Wani M.C., Gaetano K., Manikumar G., Taylor H., McGivney R. Plant antimutagenic agents, 4. Isolation and structure elucidation of maesol, an inactive constituent of Maesa spp. J. Nat. Prod. 1988;51:1226\u20131231. doi: 10.1021/np50060a028.", "ArticleIdList": ["10.1021/np50060a028", "3069959"]}, {"Citation": "Reid S.P., Shurtleff A.C., Costantino J.A., Tritsch S.R., Retterer C., Spurgers K.B., Bavari S. HSPA5 is an essential host factor for Ebola virus infection. Antiviral Res. 2014;109:171\u2013174. doi: 10.1016/j.antiviral.2014.07.004.", "ArticleIdList": ["10.1016/j.antiviral.2014.07.004", "25017472"]}, {"Citation": "Ple\u0161ko S. In Silico Study of Plant polyphenols\u2019 interactions with VP24\u2013Ebola virus matrix protein. Acta Chim. Slov. 2015;62:555\u2013564. doi: 10.17344/acsi.2015.1505.", "ArticleIdList": ["10.17344/acsi.2015.1505", "26454589"]}, {"Citation": "Lee J.E., Saphire E.O. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol. 2009;4:621\u2013635. doi: 10.2217/fvl.09.56.", "ArticleIdList": ["10.2217/fvl.09.56", "PMC2829775", "20198110"]}, {"Citation": "Zhao Y., Ren J., Harlos K., Jones D.M., Zeltina A., Bowden T.A., Padilla-Parra S., Fry E.E., Stuart D.I. Toremifene interacts with and destabilizes the Ebola virus glycoprotein. Nature. 2016;535:169\u2013172. doi: 10.1038/nature18615.", "ArticleIdList": ["10.1038/nature18615", "PMC4947387", "27362232"]}, {"Citation": "Ren J., Zhao Y., Fry E.E., Stuart D.I. Target identification and mode of action of four chemically divergent drugs against Ebola virus infection. J. Med. Chem. 2018;61:724\u2013733. doi: 10.1021/acs.jmedchem.7b01249.", "ArticleIdList": ["10.1021/acs.jmedchem.7b01249", "PMC5808380", "29272110"]}, {"Citation": "Zhao Y., Ren J., Fry E.E., Xiao J., Townsend A.R., Stuart D.I. Structures of Ebola virus glycoprotein complexes with tricyclic antidepressant and antipsychotic drugs. J. Med. Chem. 2018;61:4938\u20134945. doi: 10.1021/acs.jmedchem.8b00350.", "ArticleIdList": ["10.1021/acs.jmedchem.8b00350", "29741894"]}, {"Citation": "Shaikh F., Zhao Y., Alvarez L., Iliopoulou M., Lohans C., Schofield C.J., Padilla-Parra S., Siu S.W.I., Fry E.E., Ren J., et al. Structure-based in silico screening identifies a potent ebolavirus inhibitor from a traditional Chinese medicine library. J. Med. Chem. 2019;62:2928\u20132937. doi: 10.1021/acs.jmedchem.8b01328.", "ArticleIdList": ["10.1021/acs.jmedchem.8b01328", "PMC6441942", "30785281"]}, {"Citation": "Crystal Structure of Ebola Glycoprotein in Complex with Toremifene.  [(accessed on 1 February 2022)].  Available online:  https://www.wwpdb.org/pdb?id=pdb_00005jq7."}, {"Citation": "Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Sierra N., Folio C., Robert X., Long M., Guillon C., \u00c1lvarez G. Looking for novel capsid protein multimerization inhibitors of feline immunodeficiency virus. Pharmaceuticals. 2018;11:67. doi: 10.3390/ph11030067.", "ArticleIdList": ["10.3390/ph11030067", "PMC6161179", "29996481"]}, {"Citation": "MST Starting Guide\u2014Monolith NT. 115.  [(accessed on 1 February 2022)].  Available online:  https://physiology.case.edu/media/eq_manuals/eq_manual_nano-temper_mst_starting_guide.pdf."}, {"Citation": "Magnez R., Thiroux B., Taront S., Segaoula Z., Quesnel B., Thuru X. PD-1/PD-L1 binding studies using microscale thermophoresis. Sci. Rep. 2017;7:17623. doi: 10.1038/s41598-017-17963-1.", "ArticleIdList": ["10.1038/s41598-017-17963-1", "PMC5732298", "29247197"]}, {"Citation": "Lane T.R., Ekins S. Toward the target: Tilorone, quinacrine, and pyronaridine bind to Ebola virus glycoprotein. ACS Med. Chem. Lett. 2020;11:1653\u20131658. doi: 10.1021/acsmedchemlett.0c00298.", "ArticleIdList": ["10.1021/acsmedchemlett.0c00298", "PMC7430956", "32832035"]}, {"Citation": "Aron P.M., Kennedy J.A. Flavan-3-ols: Nature, occurrence and biological activity. Mol. Nutr. Food Res. 2008;52:79\u2013104. doi: 10.1002/mnfr.200700137.", "ArticleIdList": ["10.1002/mnfr.200700137", "18081206"]}, {"Citation": "Moini H., Rimbach G., Packer L. Molecular aspects of procyanidin biological activity: Disease preventative and therapeutic potentials. Drug Metab. Drug Interact. 2000;17:237\u2013259. doi: 10.1515/DMDI.2000.17.1-4.237.", "ArticleIdList": ["10.1515/DMDI.2000.17.1-4.237", "11201298"]}, {"Citation": "Schoonees A., Visser J., Musekiwa A., Volmink J. Pycnogenol\u00ae (extract of French maritime pine bark) for the treatment of chronic disorders. Cochrane Database Syst. Rev. 2012;4:CD008294. doi: 10.1002/14651858.CD008294.pub4.", "ArticleIdList": ["10.1002/14651858.CD008294.pub4", "22513958"]}, {"Citation": "Verstraeten S.V., Fraga C.G., Oteiza P.I. Interactions of flavan-3-ols and procyanidins with membranes: Mechanisms and the physiological relevance. Food Funct. 2015;6:32\u201340. doi: 10.1039/C4FO00647J.", "ArticleIdList": ["10.1039/C4FO00647J", "25418533"]}, {"Citation": "Hammerstone J.F., Lazarus S.A., Schmitz H.H. Procyanidin content and variation in some commonly consumed foods. J. Nutr. 2000;130:2086S\u20132092S. doi: 10.1093/jn/130.8.2086S.", "ArticleIdList": ["10.1093/jn/130.8.2086S", "10917927"]}, {"Citation": "Xu X., Xie H., Wang Y., Wei X. A-type proanthocyanidins from lychee seeds and their antioxidant and antiviral activities. J. Agric. Food Chem. 2010;58:11667\u201311672. doi: 10.1021/jf1033202.", "ArticleIdList": ["10.1021/jf1033202", "20964424"]}, {"Citation": "Cheng H.Y., Lin T.C., Yang C.M., Shieh D.E., Lin C.C. In vitro anti-HSV-2 activity and mechanism of action of proanthocyanidin A-1 from Vaccinium vitis-idaea. J. Sci. Food Agric. 2005;85:10\u201315. doi: 10.1002/jsfa.1958.", "ArticleIdList": ["10.1002/jsfa.1958"]}, {"Citation": "DeBruyne T., Pieters L., Witvrouw M., DeClercq E., Berghe D.V., Vlietinck A.J. Biological evaluation of proanthocyanidin dimers and related polyphenols. J. Nat. Prod. 1999;62:954\u2013958. doi: 10.1021/np980481o.", "ArticleIdList": ["10.1021/np980481o", "10425115"]}, {"Citation": "Quosdorf S., Schuetz A., Kolodziej H. Different inhibitory potencies of oseltamivir carboxylate, zanamivir, and several tannins on bacterial and viral neuraminidases as assessed in a cell-free fluorescence-based enzyme inhibition assay. Molecules. 2017;22:1989. doi: 10.3390/molecules22111989.", "ArticleIdList": ["10.3390/molecules22111989", "PMC6150325", "29149072"]}, {"Citation": "Cui Q., Du R., Anantpadma M., Schafer A., Hou L., Tian J., Davey R.A., Cheng H., Rong L. Identification of ellagic acid from plant Rhodiola rosea L. as an anti-Ebola virus entry inhibitor. Viruses. 2018;10:152. doi: 10.3390/v10040152.", "ArticleIdList": ["10.3390/v10040152", "PMC5923446", "29584652"]}, {"Citation": "Mikra C., Rossos G., Hadjikakou S.K., Kourkoumelis N. Molecular docking and structure activity relationship studies of nsaids. What do they reveal about IC50? Lett. Drug Des. Discov. 2017;14:949\u2013958. doi: 10.2174/1570180814666161207143231.", "ArticleIdList": ["10.2174/1570180814666161207143231"]}, {"Citation": "Rainard J.M., Pandarakalam G.C., McElroy S.P. Using microscale thermophoresis to characterize hits from high-throughput screening: A European lead factory perspective. SLAS Discov. 2018;23:225\u2013241. doi: 10.1177/2472555217744728.", "ArticleIdList": ["10.1177/2472555217744728", "PMC5824829", "29460707"]}, {"Citation": "Makabe H., Kamo T., Hirota M., Mohri Y., Sagehashi M., Yamada T., Hattori Y., Morimura K. An efficient synthesis of procyanidins using equimolar condensation of catechin and/or epicatechin catalyzed by ytterbium triflate. Heterocycles. 2009;79:549\u2013563. doi: 10.3987/COM-08-S(D)14.", "ArticleIdList": ["10.3987/COM-08-S(D)14"]}, {"Citation": "Saito A., Doi Y., Tanaka A., Matsuura N., Ubukata M., Nakajima N. Systematic synthesis of four epicatechin series procyanidin trimers and their inhibitory activity on the Maillard reaction and antioxidant activity. Bioorg. Med. Chem. 2004;12:4783\u20134790. doi: 10.1016/j.bmc.2004.07.024.", "ArticleIdList": ["10.1016/j.bmc.2004.07.024", "15336256"]}, {"Citation": "Shoji T., Mutsuga M., Nakamura T., Kanda T., Akiyama H., Goda Y. Isolation and structural elucidation of some procyanidins from apple by low-temperature nuclear magnetic resonance. J. Agric. Food Chem. 2003;51:3806\u20133813. doi: 10.1021/jf0300184.", "ArticleIdList": ["10.1021/jf0300184", "12797747"]}, {"Citation": "Tarascou I., Barathieu K., Andr\u00e9 Y., Pianet I., Dufourc E.J., Fouquet E. An improved synthesis of procyanidin dimers: Regio- and stereocontrol of the interflavan bond. Eur. J. Org. Chem. 2006:5367\u20135377. doi: 10.1002/ejoc.200600668.", "ArticleIdList": ["10.1002/ejoc.200600668"]}, {"Citation": "Hwang B.Y., Kim H.S., Lee J.H., Hong Y.S., Ro J.S., Lee K.S., Lee J.J. Antioxidant benzoylated flavan-3-ol glycoside from Celastrus orbiculatus. J. Nat. Prod. 2001;64:82\u201384. doi: 10.1021/np000251l.", "ArticleIdList": ["10.1021/np000251l", "11170672"]}, {"Citation": "Bhat R., Adam A.T., Lee J.J., Gasiewicz T.A., Henry E.C., Rotella D.P. Towards the discovery of drug-like epigallocatechin gallate analogs as Hsp90 inhibitors. Bioorg. Med. Chem. Lett. 2014;24:2263\u20132266. doi: 10.1016/j.bmcl.2014.03.088.", "ArticleIdList": ["10.1016/j.bmcl.2014.03.088", "24745965"]}, {"Citation": "Huo C., Shi G., Lam W.H., Chen D., Cui Q.C., Dou Q.P., Chan T.H. Semi-synthesis and proteasome inhibition of D-ring deoxy analogs of (\u2013)-epigallocatechin gallate (EGCG), the active ingredient of green tea extract. Can. J. Chem. 2008;86:495\u2013502. doi: 10.1139/v07-141.", "ArticleIdList": ["10.1139/v07-141"]}, {"Citation": "Vichai V., Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc. 2006;1:1112\u20131116. doi: 10.1038/nprot.2006.179.", "ArticleIdList": ["10.1038/nprot.2006.179", "17406391"]}, {"Citation": "Connor R.I., Chen B.K., Choe S., Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 1995;206:935\u2013944. doi: 10.1006/viro.1995.1016.", "ArticleIdList": ["10.1006/viro.1995.1016", "7531918"]}, {"Citation": "He J., Choe S., Walker R., Di Marzio P., Morgan P.O., Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 1995;69:6705\u20136711. doi: 10.1128/jvi.69.11.6705-6711.1995.", "ArticleIdList": ["10.1128/jvi.69.11.6705-6711.1995", "PMC189580", "7474080"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "31"}, {"Year": "2022", "Month": "2", "Day": "8"}, {"Year": "2022", "Month": "2", "Day": "23"}, {"Year": "2022", "Month": "3", "Day": "10", "Hour": "15", "Minute": "35"}, {"Year": "2022", "Month": "3", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["35269770", "PMC8910447", "10.3390/ijms23052620", "ijms23052620"]}}], "PubmedBookArticle": []}